Free Trial
NASDAQ:LFMDP

LifeMD (LFMDP) Stock Price, News & Analysis

LifeMD logo
$22.86 +0.25 (+1.08%)
As of 03/7/2025 03:50 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About LifeMD Stock (NASDAQ:LFMDP)

Key Stats

Today's Range
$22.85
$22.93
50-Day Range
$21.77
$23.35
52-Week Range
$20.01
$25.00
Volume
306 shs
Average Volume
2,381 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
9.71%
Price Target
N/A
Consensus Rating
N/A

Company Overview

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

Remove Ads
Receive LFMDP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeMD and its competitors with MarketBeat's FREE daily newsletter.

LFMDP Stock News Headlines

LifeMD announces integration with LillyDirect pharmacy provider
Is this the End of the AI Boom?
If you’re worried about all the recent volatility in the market… Or if you have any money in AI stocks… You MUST prepare for this AI event scheduled for March 18th at 1 p.m. ET.
Lake Street Sticks to Its Buy Rating for LifeMD (LFMD)
Craig-Hallum Sticks to Their Buy Rating for LifeMD (LFMD)
LifeMD® Announces Entry Into the Behavioral Health Market
See More Headlines

LFMDP Stock Analysis - Frequently Asked Questions

LifeMD's stock was trading at $22.75 on January 1st, 2025. Since then, LFMDP shares have increased by 0.5% and is now trading at $22.8650.
View the best growth stocks for 2025 here
.

Shares of LFMDP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Ex-Dividend for 1/15 Dividend
1/03/2025
Dividend Payable
1/15/2025
Today
3/09/2025
Next Earnings (Estimated)
3/10/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Health Information Services
Sub-Industry
Healthcare
Current Symbol
NASDAQ:LFMDP
Fax
N/A
Employees
230
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$193.06 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report

This page (NASDAQ:LFMDP) was last updated on 3/10/2025 by MarketBeat.com Staff
From Our Partners